A unique pharmaceutical company

Orphan Europe, part of the Recordati group, is a unique pharmaceutical company focusing on the research and development of orphan medicinal products. Since 1990 we have used big thinking and extensive know-how on behalf of people affected by rare diseases. Patients and their families are central to our planning, our thinking and our actions. Recordati orphan drugs is present in the USA through its company Recordati Rare Diseases.

News and events

Orphan Europe has launched a new phase of the campaign: “Think beyond the obvious – Think Porphyria”: A patients’ stories video subtitled in 10 languages, together with 5 patients’ testimonials

EURORDIS Awards 2014
for outstanding accomplishments in the field of rare diseases presented in honour of Rare Disease Day in Brussels